CBU
ABBV icon

CIBC Bank USA’s AbbVie ABBV Stock Holding History

CIBC Bank USA’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$3.5M Sell
39,530
-229
-0.6% -$19K 0.46% 30
2019
Q3 		$3.01M Sell
39,759
-2,664
-6% -$183K 0.43% 31
2019
Q2 		$3.08M Sell
42,423
-5,205
-11% -$409K 0.43% 33
2019
Q1 		$3.84M Sell
47,628
-1,994
-4% -$163K 0.54% 24
2018
Q4 		$4.58M Buy
49,622
+1,494
+3% +$131K 0.74% 16
2018
Q3 		$4.55M Buy
48,128
+404
+0.8% +$38.3K 0.62% 19
2018
Q2 		$4.42M Buy
47,724
+1,994
+4% +$195K 0.61% 19
2018
Q1 		$4.33M Buy
45,730
+6,160
+16% +$677K 0.59% 21
2017
Q4 		$3.83M Sell
39,570
-408
-1% -$38.5K 0.48% 24
2017
Q3 		$3.55M Buy
39,978
+1,383
+4% +$105K 0.47% 24
2017
Q2 		$2.8M Buy
38,595
+8,169
+27% +$549K 0.37% 31
2017
Q1 		$1.98M Sell
30,426
-2,137
-7% -$134K 0.27% 45
2016
Q4 		$2.04M Buy
32,563
+5,509
+20% +$336K 0.3% 44
2016
Q3 		$1.71M Sell
27,054
-366
-1% -$23.7K 0.26% 59
2016
Q2 		$1.7M Buy
27,420
+7,088
+35% +$432K 0.26% 57
2016
Q1 		$1.16M Sell
20,332
-348
-2% -$19.4K 0.2% 71
2015
Q4 		$1.23M Buy
20,680
+829
+4% +$47.7K 0.21% 73
2015
Q3 		$1.08M Sell
19,851
-831
-4% -$54.1K 0.2% 76
2015
Q2 		$1.39M Buy
20,682
+1,391
+7% +$90.8K 0.23% 66
2015
Q1 		$1.13M Sell
19,291
-1,573
-8% -$95K 0.2% 76
2014
Q4 		$1.37M Buy
20,864
+635
+3% +$40K 0.24% 69
2014
Q3 		$1.17M Buy
20,229
+4,270
+27% +$237K 0.23% 71
2014
Q2 		$901K Buy
15,959
+2,159
+16% +$113K 0.17% 100
2014
Q1 		$709K Sell
13,800
-3,925
-22% -$198K 0.15% 127
2013
Q4 		$936K Sell
17,725
-360
-2% -$17.7K 0.21% 106
2013
Q3 		$809K Sell
18,085
-84,940
-82% -$3.77M 0.2% 113
2013
Q2 		$4.26M Buy
+103,025
New +$4.51M 0.25% 74

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

CIBC Bank USA's ABBV Position: Q4 2019 in Review

CIBC Bank USA reduced its AbbVie (ABBV) stake by 0.58% in Q4 2019, selling an estimated $19K and leaving 39,530 shares worth $3.5M. The position accounts for 0.46% of the portfolio, ranked #30.

CIBC Bank USA first reported a position in ABBV in Q2 2013 and has held it in 27 quarters since. The position peaked at $4.58M in Q4 2018. 2,243 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

  • CIBC Bank USA held 39,530 shares of AbbVie worth $3.5M as of Q4 2019.
  • CIBC Bank USA sold 229 AbbVie shares in Q4 2019, an estimated $19K.
  • AbbVie made up 0.46% of CIBC Bank USA's portfolio in Q4 2019, its #30 holding.
  • CIBC Bank USA first reported a position in AbbVie in Q2 2013 and has held it in 27 quarters since.
  • CIBC Bank USA's AbbVie position peaked at $4.58M in Q4 2018.
  • 2,243 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on CIBC Bank USA's 13F filing for Q4 2019, filed 29 Jan 2020.